Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116811) titled 'Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Beijing Tiantan Hospital
Condition:
Vestibular Schwannoma
Facial Nerve Paralysis
Intervention:
Drug: Steroids therapy
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: September 1, 2025
Target Sample Size: 364
Countries of Recruitment:
China
T...